Type I IFNs signaling and apoptosis resistance in glioblastoma cells.
about
Vaccine therapies in malignant gliomaInterferons as inducers of apoptosis in malignant cellsInduction of cytopathogenicity in human glioblastoma cells by chikungunya virus.Multifaceted activities of type I interferon are revealed by a receptor antagonist.PARP targeting counteracts gliomagenesis through induction of mitotic catastrophe and aggravation of deficiency in homologous recombination in PTEN-mutant gliomaDendritic Cell-Based Vaccines that Utilize Myeloid Rather than Plasmacytoid Cells Offer a Superior Survival Advantage in Malignant Glioma.PI3K pathway inhibitors: potential prospects as adjuncts to vaccine immunotherapy for glioblastoma.Plasmacytoid dendritic cells in the tumor microenvironment: immune targets for glioma therapeutics.Convection-enhanced delivery improves distribution and efficacy of tumor-selective retroviral replicating vectors in a rodent brain tumor modelCopy Number Profiling of Brazilian AstrocytomasGrowing tumors induce a local STING dependent Type I IFN response in dendritic cells.Multiple functions of USP18.The DeISGylase USP18 limits TRAIL-induced apoptosis through the regulation of TRAIL levels: Cellular levels of TRAIL influences responsiveness to TRAIL-induced apoptosis.Tetra-O-methyl nordihydroguaiaretic acid, an inhibitor of Sp1-mediated survivin transcription, induces apoptosis and acts synergistically with chemo-radiotherapy in glioblastoma cells.Cell-type-specific innate immune response to oncolytic Newcastle disease virus.The binding landscape of a partially-selective isopeptidase inhibitor with potent pro-death activity, based on the bis(arylidene)cyclohexanone scaffold.
P2860
Q26829328-C95BB925-FAA9-4F1B-AD9D-4310103E722CQ27010207-B99BB04A-1E08-4072-A6A5-0C4E9BE74F8EQ35006024-4108E91F-CDA8-43A6-B25A-0F8ED7F92080Q35031568-3D95BE8D-77A8-45A8-A7F3-609DDE52D75DQ35741555-0E11A600-8668-4749-BF13-B57B40AC53E3Q35763478-44F936F2-DBCF-4FCA-96AC-5354137DDD3AQ36086507-42BF7174-BF90-45AE-A489-A250ACF7C1DFQ36200438-1032B2CF-E7AE-4768-B8A1-6F28D3021EA2Q37069887-4D02BA06-9586-4582-BEFE-8F0260E36247Q37079525-A5A78CEF-C32A-46A9-8D29-CAD86FC8DF83Q38775242-D7A5F8A3-5A43-4A40-B305-4726508E3B7BQ38997388-5E3622E2-B23A-4B59-B6C2-20DA65E6E340Q39072507-60F1C133-7705-486A-952B-06E703FD3AE1Q39214188-178D0BC3-7B5F-41AE-9CCD-1D524D4E5E7FQ39312501-0EBD97C4-0F9B-40C5-BEB8-82D5EC298239Q50130103-A9B5E0C0-48EE-49D8-B35E-4452E9B7E576
P2860
Type I IFNs signaling and apoptosis resistance in glioblastoma cells.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Type I IFNs signaling and apoptosis resistance in glioblastoma cells.
@en
Type I IFNs signaling and apoptosis resistance in glioblastoma cells.
@nl
type
label
Type I IFNs signaling and apoptosis resistance in glioblastoma cells.
@en
Type I IFNs signaling and apoptosis resistance in glioblastoma cells.
@nl
prefLabel
Type I IFNs signaling and apoptosis resistance in glioblastoma cells.
@en
Type I IFNs signaling and apoptosis resistance in glioblastoma cells.
@nl
P2093
P2860
P1433
P1476
Type I IFNs signaling and apoptosis resistance in glioblastoma cells
@en
P2093
Andrea Sgorbissa
Andrea Tomasella
Harish Potu
Ivana Manini
P2860
P2888
P304
P356
10.1007/S10495-011-0639-4
P577
2011-12-01T00:00:00Z